- Measured material
- Specific molecular form
- ADMET domain
- Excretion / Persistence
- Value
- 762 seconds
- Evidence role
- Comparable: structured measurement intended for within-endpoint comparison when assay context matches
- Assay / model
- Radioimmunoassay and HPLC analysis · human · Intravenous administration to human plasma
- Condition
- Dose/window: 75 μg · Time: 0, 2, 5, 7,10,15, 20, 25, 30, 45, 60, 90, 120, 150, and 180 min. · Human blood plasma proteases · in vivo
- Scientific source
DOI: 10.1210/jcem-58-1-192
Source: PEPlife2
